Articles

02 May 2007 Cephalon Presents Positive Results for FENTORA(R) in Breakthrough Pain Associated with Neuropathic Conditions
02 May 2007 Sirion Therapeutics Initiates Two Phase III Clinical Trials
02 May 2007 Optimer Pharmaceuticals Initiates Second Phase 3 Trial of OPT-80 for CDAD
02 May 2007 Accera, Inc. Announces Results of Phase II Study in Alzheimer's Disease at American Academy of Neurology Meeting
01 May 2007 Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients
01 May 2007 InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
01 May 2007 Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory Dose Doxycycline for the Treatment of Rosacea
01 May 2007 Interim report about clinical trial of BF-200 ALA in actinic keratosis
28 Apr 2007 Diovan(R) achieved 40% reduction in stroke and cardiovascular events in landmark Jikei Heart Study
28 Apr 2007 Kyowa Hakko in-licenses ARQ 197, an anticancer agent in clinical development, from the US company ArQule.
28 Apr 2007 Submission of New Drug Application for Istradefylline(KW-6002), an investigational anti-Parkinson's disease drug
28 Apr 2007 Schering-Plough Announces EU Approval Of Two New Formulations Of Aerius(R) (Desloratadine)
28 Apr 2007 Cipher Pharmaceuticals Receives Approvable Letter From Fda For CIP-ISOTRETINOIN
28 Apr 2007 VioQuest Pharmaceuticals Announces Phase I/IIa Trial and Enrollment Updates for Akt Inhibitor VQD-002
28 Apr 2007 INVEGA(R) Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia
28 Apr 2007 FDA approves once-daily Veramyst(TM) (fluticasone furoate) Nasal Spray for treatment of seasonal and year-round allergy symptoms in adults and children as young as two years
28 Apr 2007 Merck Receives Non Approvable Letter from FDA for ARCOXIA(R) (etoricoxib)
27 Apr 2007 Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds
27 Apr 2007 Novagali Pharma Announces FDA Clearance of IND for US Pivotal Phase III Trial of Nova22007 for Treatment of Dry Eye Syndrome
27 Apr 2007 SciClone Acquires Clinical-Stage Pancreatic Cancer Compound
27 Apr 2007 4SC AG: 60 Patients in Phase IIa Clinical Trial
27 Apr 2007 Alchemia reports preliminary positive efficacy data from HyCAMP Phase II trial
26 Apr 2007 Exelixis Files IND Application for XL765
26 Apr 2007 XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
26 Apr 2007 MediGene Completes Patient Recruitment for Clinical Phase II Trial of EndoTAG(R)-1

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top